EarliPoint Health Launches Project ALIGN to Advance Objective Measurement and Outcomes in Autism Care

Learn More →

Autism Assessment Age Ranges: The Complete Reference Chart

On This Page

Autism assessment tools each publish a specific age range, and the ranges do not line up neatly: the M-CHAT-R/F screens toddlers at 16-30 months, the ADOS-2 runs from 12 months through adulthood, the CARS-2 starts at age 2, and the Vineland-3 covers birth through 90 years. The chart below consolidates the verified ranges for the screeners, diagnostic instruments, adaptive and skills measures, and one FDA-cleared medical device that providers use most. Every range here comes from the publisher’s own documentation.

Master Chart: Autism Assessment Age Ranges at a Glance

Tool Type Age range Notes
M-CHAT-R/F Screener (autism-specific) 16-30 months Two-stage parent report; official instructions note studies support use up to 48 months; AAP-recommended screening at 18- and 24-month visits
ASQ-3 Screener (broad developmental) 1 month to 5 1/2 years 21 age-specific questionnaires at intervals from 2 to 60 months; general development, not autism-specific
ADOS-2 Observation 12 months through adulthood Five modules selected by chronological age plus expressive language level; Toddler Module covers 12-30 months
ADI-R Diagnostic interview (caregiver) Children and adults with a mental age above 2 years, 0 months Mental-age floor, not a chronological cutoff; no upper age limit; 90-150 minutes including scoring
CARS-2 Observation (rating scale) 2 years and older Standard form: under 6, or communication difficulties, or below-average estimated IQ; High-Functioning form: verbally fluent, 6 and older, IQ above 80
Vineland-3 Adaptive behavior measure Birth to 90 years Interview and Parent/Caregiver forms: birth-90; Teacher Form: ages 3-21
VB-MAPP Skills measure (criterion-referenced) Developmental range 0-48 months 170 milestones across three levels (0-18, 18-30, 30-48 months); for children with autism and other individuals with language delays
ABLLS-R Skills measure (criterion-referenced) No formal age band 544 skills in 25 areas benchmarked to skills most typically developing children acquire before kindergarten
EarliPoint System Medical device (eye tracking) 16-95 months FDA-cleared to aid qualified clinicians in the diagnosis and assessment of ASD in children at risk; prescription use only

M-CHAT-R/F: 16-30 Months

The Modified Checklist for Autism in Toddlers, Revised with Follow-Up, is a two-stage parent-report screener designed for toddlers between 16 and 30 months of age. The official instructions note that published studies have used it with children up to 48 months, so the tool can stretch to 16-48 months when a practice needs it to. Children who score low before 24 months should be screened again after the second birthday. The CDC’s clinician guidance calls for autism-specific screening of all children at the 18- and 24-month well-child visits. A positive screen indicates likelihood, not a diagnosis; it starts the referral clock.

ASQ-3: 1 month to 5 1/2 years

The Ages & Stages Questionnaires, Third Edition, is a broadband developmental screener rather than an autism-specific tool. It covers children from 1 month to 5 1/2 years through 21 age-specific questionnaires administered at intervals from 2 to 60 months. It shows up constantly in referral packets because pediatric practices use it for routine developmental surveillance, and a concern flagged on an ASQ-3 often precedes an autism-specific screen such as the M-CHAT-R/F. Treat it as context for the referral question, not as evidence for or against ASD.

ADOS-2: 12 Months Through Adulthood

The ADOS-2 spans 12 months through adulthood, the widest range of any observational instrument in routine use. WPS defines five modules. The Toddler Module serves children 12 to 30 months who do not consistently use phrase speech; Module 1 serves children 31 months and older at that same language level. Modules 2 through 4 are assigned by expressive language more than age: phrase speech without fluency (Module 2, any age), verbally fluent children and young adolescents (Module 3), and verbally fluent older adolescents and adults (Module 4). Module selection carries real scoring consequences, and the decision has more edge cases than this summary can hold; our guide to ADOS-2 module selection works through them.

ADI-R: Mental Age Above 2 Years, 0 Months

The ADI-R has no upper age limit. WPS specifies it for children and adults with a mental age above 2 years, 0 months, and that floor matters more in practice than any birthday: the interview collects a developmental history from caregivers, so it can inform the diagnostic picture for a 4-year-old or a 40-year-old as long as developmental level supports valid administration. Plan for 90 to 150 minutes, including scoring. It pairs with direct observation rather than replacing it. Administration and clinical use are covered in our ADI-R overview for clinicians, with score interpretation to follow in ADI-R Scoring Guide.

CARS-2: 2 Years and Older

The CARS-2 begins at age 2 with no stated upper limit, and the form choice carries its own criteria. The Standard Version (CARS2-ST) is for individuals younger than 6, and for those of any age with communication difficulties or below-average estimated IQs. The High-Functioning Version (CARS2-HF) is for verbally fluent individuals 6 years and older with IQ scores above 80. An unscored parent questionnaire (CARS2-QPC) gathers background for either form. Deciding between this instrument and an observation schedule comes down to purpose, training, and time; CARS-2 vs ADOS-2 walks through that choice, and [LINK WHEN LIVE: CARS-2 Scoring Guide] will cover the numbers.

Vineland-3: Birth to 90 Years

Pearson publishes the Vineland-3 for birth through 90 years on the Interview and Parent/Caregiver forms; the Teacher Form covers ages 3 to 21. That birth-to-90 span makes it the one instrument on this chart that can follow a person across the whole lifespan, which is why adaptive behavior data so often anchors re-evaluations and funding reviews. It measures adaptive behavior, not autism symptoms, so it sits beside a diagnostic instrument rather than in place of one. Forms and domains are covered in our Vineland-3 guide; the Vineland-3 Scoring Guide will handle interpretation.

VB-MAPP: Developmental Range 0-48 Months

The VB-MAPP measures 170 learning and language milestones balanced across three developmental levels: 0-18 months, 18-30 months, and 30-48 months. Those are developmental ranges, not chronological cutoffs. The publisher describes the tool as designed for children with autism and other individuals who demonstrate language delays, so a 6-year-old whose verbal skills fall within the 0-48 month developmental span remains an appropriate candidate. It is criterion-referenced; results place a learner against typical milestones and feed directly into program placement. Administration, barriers scoring, and IEP use are covered in the full VB-MAPP guide.

ABLLS-R: No Formal Age Band

The ABLLS-R does not publish a numeric age range. It is a criterion-referenced review of 544 skills across 25 areas, and the publisher anchors it to skills that most typically developing children acquire prior to entering kindergarten. In practice that makes it a fit for early learners and for older students still building foundational language, self-help, academic, and motor repertoires. Because it tracks skills rather than norms, chronological age never disqualifies a learner. For how it lines up against the VB-MAPP, AFLS, Vineland, and PEAK, see the ABA assessment comparison.

Which Assessments Fit at Which Age

The same facts, sorted the way referrals actually arrive.

Under 16 Months

Autism-specific screening has not formally started. This is surveillance territory: the ASQ-3 begins at 1 month, the Vineland-3 at birth, and the ADOS-2 Toddler Module can be administered from 12 months for toddlers who do not consistently use phrase speech. Most identification at this age happens in primary care, which is why the pediatrician’s role in early identification matters so much to downstream ABA timelines.

16 to 30 Months

The M-CHAT-R/F window opens at 16 months and runs to 30 months, with recommended screening at the 18- and 24-month visits. The ADOS-2 Toddler Module continues through 30 months, Module 1 takes over at 31 months, and the CARS-2 becomes available at age 2. The ADI-R becomes usable once mental age exceeds 2 years, 0 months. The EarliPoint System’s FDA-cleared range begins at 16 months, the same point the M-CHAT-R/F window opens.

Preschool, Roughly 3 to 5 Years

Every diagnostic instrument on the chart is in range. ADOS-2 module choice follows expressive language (typically the Toddler Module is behind them and Modules 1-3 apply), the CARS2-ST covers children under 6, and the ADI-R applies given its mental-age floor. On the programming side, the VB-MAPP’s milestones through the 30-48 month developmental level and the ABLLS-R’s pre-kindergarten skill set do most of the treatment-planning work.

School Age and Beyond, 6 Years and Up

The CARS2-HF becomes an option at 6 for verbally fluent individuals with IQs above 80. ADOS-2 Modules 3 and 4 cover verbally fluent school-age children through adults, the ADI-R has no upper chronological limit, and the Vineland-3 runs to age 90. The EarliPoint System’s indication extends through 95 months, which is 7 years, 11 months. Criterion-referenced skills assessments stay relevant for older learners whose repertoires fall within their developmental ranges.

Why Assessment Age Ranges Get Confusing

Chronological age is not the only clock. The ADI-R’s floor is a mental age above 2 years, 0 months, not a second birthday. The VB-MAPP’s 0-48 months describes developmental milestones, not the learner in the chair. Two tools can both say “2 years” and mean different things.

Language level can override age. ADOS-2 Modules 2 through 4 are assigned by expressive language. Depending on fluency, a 9-year-old might be appropriate for Module 1, 2, or 3; age alone never picks the module.

Screening windows are not diagnostic ranges. A screening window is the span in which a screener is validated to flag likelihood: 16-30 months for the M-CHAT-R/F. A diagnostic range is the span in which an instrument can support a diagnostic decision. A child who ages out of a screening window has not aged out of assessment, a distinction unpacked in screeners vs diagnostic tools.

[IMAGE: Horizontal timeline chart showing each tool’s verified age range as a labeled bar from birth through adulthood, with screening windows visually distinguished from diagnostic and skills-assessment ranges] Alt text: Chart of autism assessment age ranges comparing M-CHAT-R/F, ASQ-3, ADOS-2, ADI-R, CARS-2, Vineland-3, VB-MAPP, ABLLS-R, and EarliPoint System age spans. 

Frequently Asked Questions

At what age can a child be assessed for autism?

Autism-specific screening is recommended at the 18- and 24-month well-child visits, and the M-CHAT-R/F is designed to begin at 16 months. Diagnostic observation can start earlier: the ADOS-2 Toddler Module is administered from 12 months. There is no upper limit, since instruments such as the ADI-R and ADOS-2 Module 4 extend through adulthood.

What age can the ADOS be done?

The ADOS-2 covers 12 months through adulthood. The Toddler Module serves children 12 to 30 months of age who do not consistently use phrase speech, and Modules 1 through 4 cover everyone older, assigned by expressive language level as much as by age.

What is the age range for the Vineland?

The Vineland-3 Interview and Parent/Caregiver forms cover birth through 90 years. The Teacher Form covers ages 3 to 21. Because it measures adaptive behavior, it is used across the lifespan for diagnostic support, treatment planning, and re-evaluation.

What ages is the M-CHAT-R/F validated for?

The M-CHAT-R/F is designed for toddlers between 16 and 30 months of age. The official instructions note that published studies have used it with children up to 48 months. Children who score low before 24 months should be rescreened after the second birthday.

What age is the CARS-2 designed for?

The CARS-2 is for ages 2 and older. The Standard Version (CARS2-ST) fits individuals younger than 6 and those with communication difficulties or below-average estimated IQs. The High-Functioning Version (CARS2-HF) fits verbally fluent individuals 6 and older with IQ scores above 80.

Is there an upper age limit for an autism assessment?

No. The ADI-R applies to children and adults with a mental age above 2 years, 0 months, ADOS-2 Module 4 serves verbally fluent older adolescents and adults, and the Vineland-3 extends to age 90. A diagnostic question raised in adulthood is still answerable with standard instruments.

What age range does the VB-MAPP cover?

The VB-MAPP assesses 170 milestones across three developmental levels spanning 0-48 months. Those levels describe developmental skills, not chronological age, so older learners with language delays are assessed against the same milestones when their skills fall within that range.

Where the EarliPoint System Fits: 16 to 95 Months

The EarliPoint System is an FDA-cleared medical device indicated for use as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children 16 to 95 months old who are at risk based on concerns shared by a parent, caregiver, or healthcare provider.

Read against the chart above, that range starts where autism-specific screening starts: 16 months is also the age the M-CHAT-R/F window opens. It ends at 7 years, 11 months, which reaches through the years when ABA practices are running re-evaluations and updating treatment plans. The device uses eye tracking to add objective measurement to the assessment process. It complements clinical judgment rather than replacing it, and it is available by prescription only. In the master table it occupies one row among many, which is where it belongs: a medical device alongside the screeners, interviews, observations, and adaptive measures a qualified clinician already weighs.

Keep the Chart, Check the Manual

Age ranges shift across editions, and payers layer their own requirements on top of what an instrument allows, so when a range in a referral packet looks off, the publisher’s current manual settles it. Who can render the diagnosis itself varies by state licensure and payer policy; our reference on that question is coming in Who Can Diagnose Autism: A Provider Reference. Until then, this chart covers the part that stays stable longest: what each tool was built to measure, and for whom.

 

Cheryl Tierney, MD, MPH

Chief Medical Officer

Developmental pediatrician, public health advocate, and Chief Medical Officer at EarliPoint Health. Cheryl blends scientific curiosity with real-world passion — as a physician, professor, and mom, she’s committed to turning early autism research into better care and support for families.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Cheryl serves as EarliPoint’s Chief Medical Officer, helping advance early autism research into more accessible care and support for families.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder